Other languages Eris Lifesciences Limited Bombay S.E.

Equities

ERIS

INE406M01024

Market Closed - Bombay S.E. Other stock markets 11:11:41 03/05/2024 BST			5-day change	1st Jan Change
867 ^INR	-2.68%		-1.69%	-4.78%

04-03	Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business	MT
03-15	Eris Lifesciences to Acquire India Formulation Business of Biocon Biologics for INR12.42 Billion	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business	04-03
Eris Lifesciences to Acquire India Formulation Business of Biocon Biologics for INR12.42 Billion	03-15
Eris to Acquire Additional Stake in Swiss Parenterals, Take Over Branded Formulations Business of Biocon Biologics	03-14
India's Biocon to sell branded formulations business to Eris Lifesciences for $150 million	03-14
Eris Lifesciences Completes Purchase of 51% Stake in Swiss Parenterals	02-16
Eris Lifesciences Limited completed the acquisition of 51% stake in Swiss Parenterals Limited.	02-14
Eris Lifesciences Limited Provides Earnings Guidance for the Fiscal 2025 and Fiscal 2026	02-13
Eris Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13
India's Biocon posts profit on biosimilar boost, divestment gains; CFO resigns	02-08
Eris Lifesciences Limited completed the acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics	11-09
Indian shares set to open higher tracking Asian peers	11-09
Eris Lifesciences Limited Reaffirms Earnings Guidance for the Full Year of Fiscal 2024	11-08
Eris Lifesciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08
Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23
Eris Lifesciences Gains Dermatology Trademarks Acquired from Glenmark via Deal with Unit Eris Oaknet	04/07/23
Eris Lifesciences' Consolidated Profit Falls in Fiscal Q4	17/05/23
Eris Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	17/05/23
India's Glenmark Pharma weighs selling stake in Glenmark Life - Mint	11/04/23
Eris Lifesciences Completes Acquisition of Nine Dermatology Brands from Dr. Reddy's	27/03/23
Eris Lifesciences Limited completed the acquisition of Portfolio of Nine Dermatology Brands of Dr Reddy's Laboratories.	23/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Eris Lifesciences Limited Bombay S.E.

Equities

ERIS

INE406M01024

Other languages

Filters